IL33 and central nervous system cancer: In addition, RNA-seq and western blot analysis of the glioma cells show little or no detectable expression of ST2 (Supplementary Fig. 2c, d) further supporting that the secretion of IL-33 by the glioma cells is acting on other components of the tumor microenvironment.